Article
The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance).
Pharmacogenetics and genomics - 1 Jan 2013
Lewis Lionel D, Miller Antonius A, Owzar Kouros, Bies Robert R, Markova Svetlana, Jiang Chen, Kroetz Deanna L, Egorin Merrill J, McLeod Howard L, Ratain Mark J
Abstract excerpt
Docetaxel-related neutropenia was associated with polymorphisms in the drug transporters ABCC2 and SLCO1B3 in Japanese cancer patients. We hypothesized that this association is because of reduced docetaxel clearance, associated with polymorphisms in those genes. We studied 64 US cancer patients who received a single cycle of 75 mg/m of docetaxel monotherapy. We found that the ABCC2 polymorphism at rs-12762549...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
